Skip to main content

Advertisement

Table 4 Clinical conditions and health care characteristics

From: Evaluating quality of care for patients with type 2 diabetes using electronic health record information in Mexico

Medical history FMC A FMC B FMC C FMC D Total
  n = 7184 % n = 6671 % n = 7256 % n = 4019 % n = 25130 %
Duration of diabetes      
<5 years 3.8 2.5 1.6 0.9 2.4
5–10 years 12.3 6.8 5.3 10.3 8.5
11–15 years 11.6 7.3 5.2 7.5 7.9
>15 years 27.5 14.8 10.6 11.1 16.6
Missing data 44.8 68.6 77.3 70.2 64.5
Comorbidity and chronic complications      
Hypertensive disease 63.3 68.0 59.2 44.5 60.4
Other cardio-vascular disease 11.2 13.2 6.1) 4.2 9.2
Hyperlipidemia 49.2 44.3 40.2 26.1 41.6
Diabetic chronic complications 29.9 29.5 38.1 27.0 31.7
Type of chronic complication      
Peripheral vascular disease 8.9 6.8 26.8 14.9 14.5
Diabetic nephropathy 14.5 10.4 8.1 8.2 10.6
Diabetic retinopathy 7.0 12.1 6.8 4.4 7.9
Peripheral neuropathy 5.6 6.0 3.6 4.3 4.9
Nutritional status      
Nutritional status at the end of the year      
 Under weight (<18.5 kg/m2) 0.3 0.5 0.2 0.3 0.3
 Normal weight (BMI18.5- 24.9 kg/m2) 16.4 17.9 14.2 13.5 15.7
 Overweight (BMI 25.0 - 29.9 kg/m2) 35.8 35.4 36.3 36.2 35.9
 Obesity (BMI ≥30.0 kg/m2) 33.9 31.7 35.3 34.2 33.8
 Missing data 13.6 14.5 14.0 15.8 14.3
Health care characteristics      
Number of visits of the patient to the family doctor, mean (standard deviation) 8.5 (4.4) 9.6 (5.0) 8.7 (4.5) 7.9 (4.1) 8.8 (4.6)
Hypoglycemic prescriptions      
Number of hypoglycemic prescriptions      
None 20.5 18.8 14.1 9.9 16.5
1 37.1 40.9 32.3 34.0 36.2
2 38.1 37.2 43.0 46.9 40.7
≥3 4.3 3.1 10.5 9.1 6.5
Type of hypoglycemic drugs      
Metformin 57.2 62.3 65.3 67.1 37.5
Glibenclamide 51.8 46.9 58.7 61.7 45.9
Acarbose 3.3 3.2 12.5 9.7 7.0
Thiazolidinedione 0.0 0.0 1.5 0.0 0.4
Insulin 14.1 12.4 12.5 17.4 13.7
  1. Source: Family medicine clinics 2009 electronic health record information.